Clinical Trial Update: Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on allogeneic transplantation using total lymphoid irradiation and anti-thymocyte globulin in older patients with hematologic mali…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Cancer
• Leukemia

Drugs mentioned

• Anti-thymocyte globulin (ATG) (anti-thymocyte globulin)
• Total lymphoid irradiation (TLI) (Total lymphoid irradiation)

Snippet

Sponsor: Stanford University | Conditions: Blood Cancer, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-10-03